Vincent Guillaumot

Vincent Guillaumot

Managing Partner

Vincent holds over 15 years experience in the Healthcare and Private Equity sectors.

Vincent started his career at Bain & Company as a consultant before joining 3i’s Healthcare team. Prior to joining ArchiMed, Vincent was the Managing Director of JS Bio (now Cerba), a French Diagnostics company.

Vincent is a Founding Partner of ArchiMed, and is President of the Eureka Foundation, ArchiMed’s charitable foundation. Vincent has a long-standing relationship with other ArchiMed partners, since 2005. He is currently a non-executive Director in the France-headquartered Neuro-Diagnostic company Micromed, in the Austria-headquartered In-Vitro Diagnostics specialist EuroLyser, in the UK-headquartered Occupational Health firm Vita Health and in the Italy-headquartered In-Vitro Diagnostics player Diesse. Vincent also was a non-executive Director of France-headquartered Health Ingredients firm Natural Origins (formerly Herbs’ International Services – HIS, Italy-headquartered Dental company Primo and in the Switzerland-headquartered Trauma Orthopaedics company Medistream / Citieffe. Vincent leads the MED (smallcap) funds of ArchiMed. Vincent is a member of ArchiMed’s Management Committee.

Vincent graduated from l’Ecole Nationale des Ponts et Chaussées as an Engineer and holds an MSc from the University of Berkeley, United States. Vincent is a French citizen.